Insider Trading & Ownership of KUSH PARMAR

Location: San Francisco, CA
Summary: The estimated net worth of KUSH PARMAR is at least $33,102,419 dollars as of 18 Nov 2025. KUSH PARMAR is the Director, 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $32.83M. KUSH PARMAR is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $241.6K. KUSH PARMAR is the Director of Rallybio Corp and owns shares of Rallybio Corp (RLYB) stock worth about $29.2K.
Signature: /s/ Kush Parmar
All Insider Reports: All Insider Reports

Notify me when KUSH PARMAR files a new Insider Trading report.

Ownership of KUSH PARMAR

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
TRDA	Entrada Therapeutics, Inc.	Director, 10%+ Owner	$32,831,654	-$2,829,187	-7.9%	14 Nov 2025
QTTB	Q32 Bio Inc.	Director	$241,560			15 Jun 2022
RLYB	Rallybio Corp	Director	$29,205			15 May 2024
AKUS	Akouos, Inc.	Director, 10%+ Owner				30 Nov 2022
VOR	Vor Biopharma Inc.	Director, 10%+ Owner				14 Jun 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.